17119-73-2

Basic information

• Product Name: 4-Chloro-6-methyl-2-(methylthio)pyrimidine
• Synonyms: 4-CHLORO-6-METHYL-2-METHYLSULFANYL-PYRIMIDINE;4-Chloro-6-methyl-2-(methylthio)pyrimidine;4-chloro-6-methyl-2-(methylthio)pyrimidine(SALTDATA: FREE);4,6-dichloro-2-MethylpyriMidine-1-thiol;NSC 48354;4-Chloro-6-methyl-2-(methylthio)
• CAS NO: 17119-73-2
• Molecular Formula: C₆H₇ClN₂S
• Molecular Weight: 174.65
• EINECS: 228-577-6
• Product Categories: Heterocycle-Pyrimidine series
• Mol File: 17119-73-2.mol

Chemical Properties

• Melting Point: 37-38℃
• Boiling Point: 147°C/32mmHg(lit.)
• Flash Point: 114.8±21.8 °C
• Appearance: /
• Density: 1.3±0.1 g/cm³
• Vapor Pressure: 0.0144mmHg at 25°C
• Refractive Index: 1.581
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: Chloroform (Sparingly), MEthanol (Slightly)
• PKA: 0.16±0.30(Predicted)
• CAS DataBase Reference: 4-Chloro-6-methyl-2-(methylthio)pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-6-methyl-2-(methylthio)pyrimidine(17119-73-2)
• EPA Substance Registry System: 4-Chloro-6-methyl-2-(methylthio)pyrimidine(17119-73-2)

Safety Data

• Statements: 22
• Safety Statements: 36/37
• Hazardous Substances Data: 17119-73-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Chloro-6-methyl-2-(methylthio)pyrimidine is used as an intermediate in the synthesis of various pharmaceutical compounds. Its specific application is in the synthesis of 4-chloro-2-(3,5-dimethyl-1h-pyrazol-1-yl)-6-methylpyrimidine, which is a compound with potential therapeutic properties. The synthesis of such compounds is crucial for the development of new drugs and therapies in the pharmaceutical industry.
Used in Chemical Synthesis:
In the chemical industry, 4-Chloro-6-methyl-2-(methylthio)pyrimidine serves as a key building block for the creation of more complex molecules. Its unique structure allows for further functionalization and modification, making it a valuable component in the synthesis of a wide range of chemical products. This versatility in chemical synthesis contributes to its importance in various applications across different industries.

InChI:InChI=1/C6H7ClN2S/c1-4-3-5(7)9-6(8-4)10-2/h3H,1-2H3

Upstream product

• 6328-58-1 4-Hydroxy-6-methyl-2-methylthiopyrimidine 
• 6299-25-8 4,6-Dichloro-2-(methylthio)pyrimidine 
• 75-16-1 methylmagnesium bromide 
• 49844-90-8 4-Chloro-2-methylthiopyrimidine 
• 917-54-4 methyllithium 
• 676-58-4 methylmagnesium chloride 
• 56-04-2 6-methyl-2-thiouracil 
• 74-88-4 methyl iodide 
• 56-04-2 4-hydroxy-6-methylpyrimidine-2(1H)-thione 
• 6328-58-1 6-methyl-2-methylsulfanyl-3H-pyrimidin-4-one 

Downstream Products

• 55749-33-2 4-methoxy-6-methyl-2-methylsulfanyl-pyrimidine 
• 109389-09-5 4-benzylamino-6-methyl-2-methylthiopyrimidine 
• 14001-63-9 2-methylthio-4-methylpyrimidine 
• 24888-93-5 6-methyl-2-(methylsulfanyl)pyrimidin-4-amine 
• 6310-04-9 6-methyl-2-methylsulfanyl-3H-pyrimidine-4-thione 
• 1980-54-7 4-hydrazino-6-methyl-2-(methylsulfanyl)pyrimidine 
• 1980-55-8 2,4-dihydrazinyl-6-methylpyrimidine 
• 93669-44-4 6-Methyl-4-N-methylanilino-2-methylthiopyrimidine hydrochloride 
• 6310-04-9 2-(Methylthio)-6-methyl-pyrimidin-thiol-(4) 
• 55329-22-1 4-chloro-6-methyl-2-(methylsulfonyl)pyrimidine 
• 15231-48-8 4-methyl-1H-pyrimidin-2-one 
• 626-48-2 6-Methyluracil 
• 61000-87-1 4-methoxy-6-methyl-1H-pyrimidin-2-one 
• 57268-32-3 4-methoxy-6-methyl-2-methylsulphonyl-pyrimidine 

Relevant articles and documents

Some Features of the Reaction of 6-Methyl-2S-substituted Pyrimidin-4-ols with the Vilsmeier–Haack Reagent

Abstract: Formylation of 6-methyl-2S-substituted pyrimidin-4-ols under the conditions of the Vilsmeier–Haack reaction leads to the formation of nucleophilic substitution products of the hydroxyl group. The formation of the expected formylation products does not occur.

Synthesis and preliminary biological properties assessment of novel 2-s-, 4-, 5-substituted and bicyclic derivatives of 6-methylpyrimidine-4-ol

A series of novel 2-S-, 4-, 5-substituted and bicyclic 6-methylpyrimidine-4-ol derivatives including pyrazole, 1,2,4-triazole and pyridazine moieties in the molecule were synthesized by accessible and efficient methods. Thiopyrazolyl derivatives were obta

1-(Pyrimidin-4-yl)pyrazol-5(4H)-one derivatives: I. Synthesis of 3-methyl-1-(6-methyl-2-methylsulfanylpyrimidin-4-yl)-pyrazol-5-ol and specificity of its Knoevenagel reaction

3-Methyl-1-(6-methyl-2-methylsulfanylpyrimidin-4-yl)-1H-pyrazol-5-ol available via cyclocondensation of 6-methyl-2-methylsulfanylpyrimidin-4- ylhydrazine with ethyl acetoacetate reacted with aromatic aldehydes to give two kinds of products, 4-arylmethylid

Substituted 5-Hetaryl-4-Aminopyrimidines

The present invention relates to the use of 5-hetaryl-4-aminopyrimidines of the formula I and their salts for controlling plant-damaging fungi. The invention also relates to novel 5-hetaryl-4-aminopyrimidines and to crop protection compositions comprising at least one such compound as active component. Het is an optionally substituted 5- or 6-membered aromatic heterocycle which has 1, 2, 3 or 4 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur as ring members, where the 5- or 6-membered heteroaromatic radical may have 1, 2, 3 or 4 identical or different substituents L, R1, R2 are inter alia hydrogen, C1-C8-alkyl, C3-C8-cycloalkyl, C5-C10-bicycloalkyl, C2-C8-alkenyl, C4-C10-alkadienyl, C3-C6-cycloalkenyl, C2-C8-alkynyl, phenyl, naphthyl or a five- or six-membered saturated, partially unsaturated or aromatic heterocycle which has one, two, three or four heteroatoms from the group consisting of O, N or S as ring members; or together form a ring; R3 is inter alia hydrogen, OH, halogen, cyano, NR31R32, C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylthio, C1-C8-alkylsulfinyl, C1-C8-alkylsulfonyl, C2-C8-alkenyl or C2-C8-alkynyl, and R4 is halogen, cyano, hydroxyl, mercapto, N3, C1-C6-alkyl, C2-C8-alkenyl, C2-C8-alkynyl, C1-C6-haloalkyl, C1-C6-alkoxy, C3-C8-alkenyloxy, C3-C8-alkynyloxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C3-C8-alkenylthio, C3-C8-alkinylthio, C1-C6-haloalkylthio, or is a radical of the formula C(═Z)OR41, C(═Z)NR42R43, C(═Z)NR44—NR42R43, C(═Z)R45, CR46R47—OR48, CR46R47—NR42R43, ON(═CR49R50), O—C(═Z)R45, NR42R43a, NR51(C(═Z)R45), NR51(C(═Z)OR41), NR51(C(═Z)—NR42R43), NR52a(N═CR49R50), NR52NR42R43, NR52OR41 or C(═N—X—R45)SR41.

Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant

Pyrimidine usually has good pharmacokinetic properties as a drug substance and considerable efforts have been devoted to develop pyrimidine derivatives into drug candidates. Arylpiperazine-containing pyrimidine 4-carboxamide derivatives were synthesized and evaluated for binding to serotonin receptors and transporter. Pyrimidine derivatives showed good antidepressant activity in FST (forced swimming test) animal model and also displayed no appreciable inhibitory activity against hERG channel blocking assay. Herein SAR studies of pyrimidine derivatives targeting serotonin receptors and transporter will be disclosed.

METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHA

The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments. (Formula I)

PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER

The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer.

NOVEL SUBSTITUTED IMIDAZOLE DERIVATIVES

The present invention relates to a compound represented by Formula [I] or a pharmaceutically acceptable salt or ester thereof: wherein: X1, X2, X3, and X4, which may be identical or different, are each C or N, provided that none to two of X1, X2, X3, and X4 is/are N; Y is CH or N; R1, R1', R2, R2', R3, R3', R4, and R4', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R5 is a hydrogen atom or a methyl group; R6 and R7, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R8 and R8', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R9 is an aryl group or a heteroaryl group which may be substituted; and n is an integer from 1 to 3, and a PLK1 inhibitor or an anticancer agent containing the same.

PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα

The invention is directed to Compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.

SELECTIVE INHIBITORS AGAINST Cdk4 AND Cdk6 HAVING AMINOTHIAZOLE SKELETON

The present invention relates to a compound represented by Formula [I]: wherein X is O, S, NH or CH 2 ; Y 1 , Y 2 , Y 3 , Y 4 and Y 5 , which may be identical or different, are each CH or N; however, at least one of Y 1 , Y 2 , Y 3 , Y 4 and Y 5 is N; Z 1 and Z 2 , which may be identical or different, are each CH or N; n is an integer from 1 to 3; R 1 is a C 3 -C 8 cycloalkyl group, a C 6 -C 10 aryl group, an aliphatic heterocyclic ring or an aromatic heterocyclic ring, or a bicyclic aliphatic saturated hydrocarbon group; R 2 and R 3 , which may be identical or different, are each a hydrogen atom, a lower alkyl group, a lower alkenyl group, a C 3 -C 8 cycloalkyl group, a C 6 -C 10 aryl group, an aromatic heterocyclic ring, or the like; and R 4 is a hydrogen atom, a lower alkyl group, a C 3 -C 6 cycloalkyl group or the like, or a pharmaceutically acceptable salt or ester thereof, and a selective inhibitor against Cdk4 and/or Cdk6 or an anticancer agent containing the compound or a pharmaceutically acceptable salt or ester thereof.